They write
In 2022, the U.S. cannabis seed market was valued at $567.76 million and is projected to grow at a compound annual growth rate (CAGR) of 17.2%, reaching $2.02 billion by 2030, according to Data Bridge Market Research. This rapid growth, fueled by legalization efforts and the rise of home cultivation, represents a golden opportunity for European leaders like Blimburn Seeds, Royal Queen Seeds, ILGM and Zamnesia.
Blimburn, for instance, reports annual sales of 12 to 15 million seeds globally, with approximately 8 million sold in the U.S. alone. The company generates close to €8 million ($8.24 million) annually, evidencing the growing demand for quality cannabis seeds, particularly among home growers. Similarly, ILGM (I Love Growing Marijuana), founded in 2012, highlights its significant reach, having reportedly sold more than 30 million seeds to one million home growers across the U.S. since its inception.
Royal Queen Seeds and Zamnesia, though not sharing sales figures publicly, remain key players in the competitive cannabis seed market. From Blimburn’s pioneering work in feminized seeds to ILGM’s direct engagement with millions of growers, European companies are leveraging innovative strategies to cater to an increasingly empowered group of cannabis consumers. Their success is rooted in cultural insight, operational adaptability and a strong focus on high-quality genetics that home growers trust.
